Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» weight loss
weight loss
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
Motley Fool
Wed, 08/2/23 - 10:16 am
Ozempic
Novo Nordisk
weight loss
diabetes
Eli Lilly's Mounjaro shortage worsens ahead of potential obesity FDA approval
Fierce Pharma
Wed, 07/26/23 - 11:26 am
Eli Lilly
Mounjaro
obesity
weight loss
drug shortages
New weight loss drugs carry high price tags and lots of questions for seniors
Medical Marketing and Media
Tue, 07/25/23 - 08:53 pm
Seniors
Wegovy
Novo Nordisk
Mounjaro
Eli Lilly
weight loss
Ozempic Sales Are Soaring -- Here's Why They Could Go Even Higher
Motley Fool
Thu, 07/6/23 - 11:17 am
Novo Nordisk
Ozempic
obesity
diabetes
weight loss
addiction
More payers could stanch off-label use of Ozempic
Medical Marketing and Media
Mon, 06/19/23 - 10:24 am
Novo Nordisk
Ozempic
off-label
weight loss
Could Pfizer Have an Ozempic Killer on the Way?
Motley Fool
Mon, 06/5/23 - 10:07 am
Pfizer
danuglipron
Novo Nordisk
Ozempic
weight loss
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
Wed, 05/31/23 - 11:08 am
obesity
weight loss
Novo Nordisk
Eli Lilly
Pfizer
Amgen
This Could Be Novo Nordisk's Next Big Weight-Loss Product
Motley Fool
Wed, 05/31/23 - 10:56 am
Novo Nordisk
weight loss
Wegovy
oral Wegovy
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Investors Business Daily
Tue, 05/23/23 - 11:19 am
Pfizer
Novo Nordisk
weight loss
Ozempic
danuglipron
clinical trials
Novo Nordisk’s trial of oral semaglutide meets primary endpoint
Clinical Trials Arena
Tue, 05/23/23 - 09:56 am
Novo Nordisk
semaglutide
oral semaglutide
clinical trials
weight loss
Novo Nordisk pauses Wegovy marketing projects to dampen demand
Fierce Pharma
Mon, 05/22/23 - 11:54 am
Novo Nordisk
Wegovy
weight loss
DTC advertising
Six-month Ozempic shortage mostly over after weight-loss craze drained supply
Seattle Times, WA
Mon, 03/20/23 - 04:39 pm
Novo Nordisk
drug shortages
Ozempic
diabetes
weight loss
Just announced: upcoming late-stage clinical trials in weight loss and diabetes
Clinical Trials Arena
Sun, 10/23/22 - 07:09 pm
clinical trials
Eli Lilly
Novo Nordisk
weight loss
diabetes
Ozempic
Wegovey
Mounjaro
Novartis' former weight loss med Sanorex at center of New Jersey pharma chief's guilty plea
Fierce Pharma
Tue, 08/16/22 - 10:56 am
Novartis
Sanorex
weight loss
legal
Alain Bouaziz
Vivus’ Qsymia beats out weight loss competitors in pricing watchdog's latest cost-effectiveness analysis
Endpoints
Wed, 07/13/22 - 08:22 pm
Vivus
Qsymia
weight loss
ICER
Novo Nordisk
Saxenda
Wegovy
ADA: Eli Lilly's stellar tirzepatide weight loss data tee up showdown with Novo Nordisk's Wegovy, analysts say
Fierce Pharma
Mon, 06/6/22 - 11:42 pm
Eli Lilly
Mounjaro
tirzepatidem diabetes
weight loss
Weigh to Go: Gelesis Boasts Positive Results for Weight Loss Treatment
BioSpace
Thu, 05/5/22 - 10:24 am
PureTech Health
Gelesis Holdings
clinical trials
GS200
diabetes
obesity
weight loss
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
Xconomy
Thu, 02/13/20 - 11:39 pm
Eisai
lorcaserin
Belviq
cancer
FDA
weight loss
Servier begins manslaughter trial over weight loss drug
Endpoints
Mon, 09/23/19 - 07:32 pm
Servier
patient deaths
weight loss
Mediator
The Implications of Obesity as a Disability in Europe
Motley Fool
Sun, 07/20/14 - 09:10 am
obesity
weight loss
Arena Pharmaceuticals
Belviq
Orexigen
Vivus
Eisai
Qsymia
NB32
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »